HOXA5 and pancreatic adenocarcinoma: HOXA5 positively correlated with ESCA, HNSC, and PAAD tumor status (high expression increases cancer risk), and negatively correlated with BRCA, COAD, and LUAD status (low expression increases cancer risk).